Hospira, Inc. (NYSE:HSP)

CAPS Rating: 2 out of 5

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care.

Caps

How do you think HSP will perform against the market?

Add Stock to CAPS Watchlist

All Players

128 Outperform
30 Underperform
 

All-Star Players

28 Outperform
9 Underperform
 

Wall Street

10 Outperform
3 Underperform
 

Top HSP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

traderpat9 (75.11)
Submitted December 31, 2008

HOSPIRA-AN ABBOTT SPINOFF/GOING TO CONTINUE TO GROW DURING GOOD TIMES OR BAD

gailwood (98.43)
Submitted August 24, 2006

Overvalued.

HSP VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about HSP.

Recs

0
Member Avatar TMTAirborne (84.67) Submitted: 8/4/2015 7:29:44 PM : Underperform Start Price: $89.60 HSP Score: +23.15

--FDA Warns Against Use of Hospira Infusion Pumps (August 1 & 3, 2015) The US Food and Drug Administration (FDA) is urging hospitals to stop using certain drug infusion pumps from Hospira. The devices could be accessed by unauthorized users through a hospital's network. The FTP and telnet ports on the devices are open and Port 8443 has a default login password. Once accessed, the pumps could be manipulated to alter drug dosages. One of the affected devices, the Hospira Simbiq Infusion Pump, has been discontinued, but is still in use at some medical facilities.
Other affected devices include the Plum A+ Infusion System v.13.4 and earlier, and the Plum A+ Infusion System v. 13.6 and earlier. Hospira plans to issue updates.
http://www.bbc.com/news/technology-33759428

Plus I find it overvalued, PE and sales.

Recs

0
Member Avatar lejaha (< 20) Submitted: 5/19/2014 5:08:02 PM : Outperform Start Price: $48.00 HSP Score: +49.58

This stock will outperform. They will continue to produce results similar the first quarter for the next few quarters.

Recs

0
Member Avatar browndovecapital (54.07) Submitted: 1/7/2012 9:43:16 PM : Outperform Start Price: $30.36 HSP Score: +93.16

dddd

Leaderboard

Find the members with the highest scoring picks in HSP.

Score Leader

thegormansmke

thegormansmke (90.74) Score: +137.66

The Score Leader is the player with the highest score across all their picks in HSP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
CNBL 26.14 4/5/2013 Outperform NS $30.54 +194.53% +68.12% +126.42 0 Comment
mrsulli 42.74 5/2/2013 Outperform 3M $31.64 +184.29% +62.85% +121.44 0 Comment
monkey222 < 20 12/2/2011 Outperform 5Y $27.99 +221.36% +105.82% +115.55 1 Comment
hayrettin 70.66 5/3/2013 Outperform 5Y $33.28 +170.32% +60.81% +109.52 0 Comment
browndovecapital 54.07 1/9/2012 Outperform 5Y $30.36 +196.28% +103.12% +93.16 1 Comment
bradford86 99.78 1/9/2012 Outperform 5Y $30.36 +196.28% +103.12% +93.16 1 Comment
jjccforth < 20 1/2/2012 Outperform 1Y $30.51 +194.82% +106.31% +88.51 0 Comment
nywriter21 61.37 2/11/2013 Outperform 5Y $35.01 +156.93% +71.51% +85.41 0 Comment
joseph714 < 20 11/15/2006 Outperform NS $31.92 +181.80% +97.44% +84.36 0 Comment
introscop 93.05 6/24/2010 Underperform 5Y $57.19 +57.28% +141.54% +84.25 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBMOCapital < 20 2/9/2015 Outperform NS $87.46 +2.85% +26.97% -24.11 0 Comment
TrackCreditSuiss 90.68 11/20/2014 Outperform NS $58.42 +53.97% +27.28% +26.69 0 Comment
TrackUBS 91.96 12/15/2011 Underperform NS $28.76 +212.76% +112.03% -100.73 0 Comment
TrackRBCCapMkts 88.57 10/27/2011 Underperform NS $31.10 +189.23% +101.82% -87.40 0 Comment
TrackBarclaysCap 90.69 10/19/2011 Underperform NS $29.73 +202.56% +112.18% -90.37 0 Comment
TrackZacks < 20 10/19/2011 Underperform 3M $29.64 +24.19% +16.17% -8.02 3/15/2012 @ $36.81 1 Comment
TrackTiconderoga 88.04 10/5/2011 Outperform NS $36.54 -19.54% +8.74% -28.28 10/19/2011 @ $29.40 0 Comment
TrackZacks < 20 4/12/2011 Underperform 3M $56.16 +3.51% +1.65% -1.86 4/25/2011 @ $58.13 1 Comment
TrackCollinsStew 75.76 2/14/2011 Outperform NS $54.36 +65.47% +95.44% -29.97 0 Comment
TrackBarclaysCap 90.69 1/18/2011 Outperform NS $56.68 -29.98% -9.19% -20.78 9/13/2011 @ $39.69 0 Comment
TrackZacks < 20 10/26/2010 Outperform 3M $58.66 -12.97% +9.91% -22.88 2/2/2011 @ $51.05 1 Comment
TrackZacks < 20 7/28/2010 Outperform 3M $52.72 +8.31% +3.10% +5.20 9/27/2010 @ $57.10 1 Comment
TrackMuhlenkamp 44.98 6/30/2010 Outperform NS $57.45 +56.57% +155.67% -99.10 0 Comment
TrackGoldmanSach 76.47 5/5/2010 Outperform 5Y $55.61 -1.17% +13.89% -15.06 5/17/2011 @ $54.96 1 Comment
TrackLongbow 97.17 9/22/2009 Outperform NS $44.50 +102.13% +142.80% -40.66 0 Comment
TrackLeerinkSwan 95.42 3/25/2009 Outperform NS $28.88 +211.46% +223.40% -11.94 0 Comment
TrackBobOlstein < 20 3/2/2009 Outperform 1Y $22.81 +149.93% +55.87% +94.06 9/30/2010 @ $57.01 3 Comments
TrackJohnRogers 71.99 12/3/2008 Outperform 1Y $28.03 +220.91% +219.83% +1.07 4 Comments
TrackJimCramer 85.14 7/10/2008 Outperform 3W $39.02 +130.52% +115.59% +14.93 0 Comment
TrackEdwardOwens 99.55 9/30/2007 Outperform NS $41.45 +117.01% +78.53% +38.48 3 Comments
TrackBofASec 93.77 1/9/2007 Outperform NS $34.90 +157.74% +95.26% +62.48 0 Comment
TrackJPMorgan 90.79 8/10/2006 Outperform NS $35.56 +51.27% -6.10% +57.36 4/30/2010 @ $53.79 0 Comment

Featured Broker Partners